Home
  • Home
  • Resources
  • Diseases
  • Training
  • Evaluation
    • The Tool
    • The Tutorial
  • SYSVAC
    • About
    • Registry
    • E-learning courses
  • News
  • Webinars
  • Network
    • Steering Committee
    • Vision and Mission
    • Map
    • Meetings
    • Partners
    • Join us
  • Home
  • Resources

Resources

Selected

No filters selected.

Type of publications
  • Guidelines (30)
  • NITAG documentation (1581)
  • Reports (55)
  • SAGE documentation (211)
  • Scientific publications (111)
  • Systematic reviews (SYSVAC) (2623)
Topics
Regions
  • Africa (259)
  • Americas (759)
  • Eastern Mediterranean (43)
  • Europe (693)
  • South-East Asia (77)
  • Western Pacific (192)
Countries
Diseases
  • Chikungunya (6)
  • Cholera (33)
  • COVID-19 (1432)
  • Dengue (39)
  • Diphtheria (78)
  • Ebola (16)
  • Escherichia coli (ETEC) (2)
  • Haemophilus influenzae type B (66)
  • Hepatitis A (64)
  • Hepatitis B (149)
  • Hepatitis C (4)
  • Hepatitis E (4)
  • Herpes simplex (1)
  • Herpes zoster (63)
  • HIV / AIDS (10)
  • Human papillomavirus (HPV) (452)
  • Influenza (559)
  • Japanese encephalitis (34)
  • Lyme disease, Borreliosis (1)
  • Malaria (27)
  • Measles (124)
  • Meningococcal disease (143)
  • Mpox (52)
  • Mumps (46)
  • Pertussis (100)
  • Pneumococcal disease (262)
  • Poliomyelitis (79)
  • Q fever (1)
  • Rabies (27)
  • Rotavirus (113)
  • RSV (Respiratory syncytial virus) (44)
  • Rubella (63)
  • Salmonella (2)
  • Shigella (1)
  • Smallpox (16)
  • Streptococcus group B (6)
  • Tetanus (56)
  • Tick-borne encephalitis (11)
  • Tuberculosis (71)
  • Typhoid (23)
  • Varicella (69)
  • Yellow fever (40)
  • Zika (1)
Vaccine topics
Target population
Methodological quality (AMSTAR 2)
Publication date
Available to download in languages
2025 ∙ WHO
WHO position paper on Respiratory Syncytial Virus (RSV)
Position paper RSV (Respiratory syncytial virus)
Download:
  • EN
2025 ∙ Blukacz, A. Obach, A. Vasquez, P. Campana, C. Huerta, C. Bernal, Y. Cabieses, B.
Determinants of COVID-19 and non-COVID-19 vaccine confidence in low- and middle-income countries: A systematic review of qualitative evidence and thematic synthesis
Low and Middle Income Countries All age groups COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Zhou, G. Dael, N. Verweij, S. Balafas, S. Mubarik, S. Rengerink, K. O. Pasmooij, A. M. G. van Baarle, D. Mol, P. G. M. de Bock, G. H. Hak, E.
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and severe outcomes in adults: a systematic review and meta-analysis of European studies published up to 22 January 2024
Adolescents Adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Azam, B. Marti, M. Goel, A. Aggarwal, R.
Immunogenicity, Efficacy, and Effectiveness of Two-Dose and Shorter Schedules of Hepatitis E Vaccine: A Systematic Review
All age groups Hepatitis E Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Yeshiwas, A. G. Tsega, T. D. Denku, C. Y. Jember, M. N. Aynalem, Z. B. Ayalew, M. D. Wondimu, A. T. Alemu, A. S. Tessema, M. T. Mehari, M. G. Berihun, S. Bayeh, G. M.
Mpox vaccine acceptance and its predictors among people who have risky sexual practices: A systematic review and meta-analysis
All age groups Mpox Acceptance
Rating:
Not applicable
2025 ∙ Hegazi, M. A. Sayed, M. H. Butt, N. S. Alahmadi, T. S. Zubairi, N. A. Elson, W. A.
Navigating the shots: Parental willingness to immunize their children with COVID-19 vaccines in Saudi Arabia explored through a systematic review and meta-analysis
Parents/caregivers Saudi Arabia COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Yappalparvi, A. Gaidhane, S. Padmapriya, G. Kaur, I. Lal, M. Iqbal, S. Prasad, G. V. S. Pramanik, A. Sharma, P. Malik, P. Vishwakarma, T. Punia, A. Jagga, M. Mehta, R. Sah, S. Shabil, M. Satapathy, P. Bushi, G. Parsa, A. D. Kabir, R.
Prevalence of Mpox Vaccine Acceptance Among Students: A Systematic Review and Meta-Analysis
Adolescents Adults Mpox Acceptance
Rating:
Not applicable
2025 ∙ Yappalparvi, A. Khatib, M. N. Balaraman, A. K. Rekha, M. M. Kaur, M. Sharma, G. C. Sudan, P. Naidu, K. S. Singh, R. Ramashankar, S. Khati, K. Chauhan, S. S. Verma, L. Sidhu, A. Mehta, R. Sah, R. Gaidhane, A. M. Shabil, M. Chipeta, J. C. Bushi, G.
Prevalence of Mpox vaccine acceptance and hesitancy among people living with HIV: a comprehensive systematic review and meta-analysis
All age groups Mpox Acceptance
Rating:
Not applicable
2025 ∙ Askar, M. Ali, K. A. Batke, M. Brugger, T. Falman, A. Robertson, A. H. Perez, J. J. Johansen, K. de Jonge, J. Krause, T. G. Kulper-Schiek, W. Meerpohl, J. J. Melidou, A. Nohynek, H. Olmedo, C. Olsson, K. Pavlopoulou, I. Piechotta, V. Rubin, J. Schlaberg, J. Schmucker, C. Siemens, W. Stratil, J. Ucakar, V. Wichmann, O. Harder, T.
Relative Efficacy, Effectiveness and Safety of Newer and/or Enhanced Seasonal Influenza Vaccines for the Prevention of Laboratory-Confirmed Influenza in Individuals Aged 18 years and Over: Update of a Systematic Review
Adults Older adults Influenza Efficacy/effectiveness Safety
Rating:
High
2025 ∙ Li, Y. Liu, Z. Zhou, L. Li, R.
Willingness to pay for vaccines in China: A systematic review and single-arm Bayesian meta-analysis
All age groups China Economic aspects Acceptance
Rating:
Not applicable
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • ...
  • Home
  • Resources
  • Diseases
  • Training
  • Evaluation
  • SYSVAC
  • News
  • Webinars
  • Network
  • Sign in / Register
National Immunization Technical Advisory Groups
  • Home
  • Resources
  • Diseases
  • Training
  • Evaluation
  • SYSVAC
  • News
  • Webinars
  • Network
© 2025
  • Legal Notice
Subscription to the monthly updates

At the end of each month, we share the latest NITAG recommendations from across all regions, highlight key articles related to NITAG activities, and provide important announcements. Stay informed - don’t miss out!

Loading...